US513030A - Machine for waxing or coating paper - Google Patents

Machine for waxing or coating paper Download PDF

Info

Publication number
US513030A
US513030A US513030DA US513030A US 513030 A US513030 A US 513030A US 513030D A US513030D A US 513030DA US 513030 A US513030 A US 513030A
Authority
US
United States
Prior art keywords
machine
roll
waxing
rolls
fabric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
Publication date
Application granted granted Critical
Publication of US513030A publication Critical patent/US513030A/en
Anticipated expiration legal-status Critical
Application status is Expired - Lifetime legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/44Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating
    • C23C16/52Controlling or regulating the coating process
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B31MAKING ARTICLES OF PAPER, CARDBOARD OR MATERIAL WORKED IN A MANNER ANALOGOUS TO PAPER; WORKING PAPER, CARDBOARD OR MATERIAL WORKED IN A MANNER ANALOGOUS TO PAPER
    • B31BMAKING CONTAINERS OF PAPER, CARDBOARD OR MATERIAL WORKED IN A MANNER ANALOGOUS TO PAPER
    • B31B50/00Making rigid or semi-rigid containers, e.g. boxes or cartons
    • B31B50/60Uniting opposed surfaces or edges; Taping
    • B31B50/62Uniting opposed surfaces or edges; Taping by adhesives

Description

(No Model.) 3 Sheets-Sheet 3, J. W. BLISS & J. O. ERWIN.

MACHINE FOR WAXING OR GOATING PAPER. .No. 513,030. Patented Jan. 16, 1894.

[Efiaasvear I fiwen/Zbnr.

3 Sheets-Shet 2.

J. W. BLISS & J. G. ERWI-N. MACHINE FOR WAXING 0R COATING PAPER. No. 513,030.

(-No Model.)

Patented Jan. 16, 1894.

fiwerai'onr.

I Zawk QQW (No Model.)

. A r 3 Sheets-Sheet 3.

J. W. BLISS 8v J. C. ERWIN.-

MACHINE FOR WAXING OR COATING PAPER. N0. 513,030. Patented Jan. 16,1894.

IIIH

lmmllllIl|lII|IllII|lllllllllllllllllllllllll IIIIIIE MLIIIIIHIHHII UNITED STATES PATENT Fries.

J OHN W. BLISS AND JOHN C. ERWIN, EIJKHART, INDIANA.

MACHINE FOR WAXING OR-COATING PAPER.

SPECIFICATION forming part of Letters Patent No. 513,030, dated January 16, 1894.

I Application filed July 23, 1892. Serial No. 441,078. (No model.)

To all whom it may concern:

Be it known that we, JOHN W. BLISS and JOHN G. ERWIN, citizens of the United States, residing at Elkhart, in the county of Elkhart and State of Indiana, have invented new and useful Improvements in Machines for Waxing or Coating Paper or other Fabrics, of which the following is a specification.

Our invention relates to the improved mech anism or apparatus for applying the wax or other substance used, to paper or other fabric, pressing and calendering the web of fabric under treatment, and automatically detecting holes or broken places in the web of paper, and preventing such broken and unmarketable portions from receiving wax or other substance, by severing the web, the object being to provide a combination of mechanism into one machine that will accomplish these results in the most rapid and economical manner.

We attain our object by the apparatus illustrated in the accompanying drawings, in which Figure 1 is a vertical, side elevation of the machine. Fig. 2 is a vertical sectional,front elevation of a portion of the machine. Fig. 3 is a top view of a portion of the machine, and Figs. 4, 5, 6 and 7 represent separate parts or portions of the machine, referred to but not clearly shown in Figs. 1, 2 and 3.

Similar letters refer to similar parts throughout the several views.

Referring to the drawingsz-A A, B B, and G O, constitute the frames or supports on each side of the machine.

Paraffine wax, or other material to be used, is prepared in a suitable receptacle or tank, conveniently located, from which it is drawn into the vat or pan F in which the hollow roll G is located with one third or more of its diameter submerged in the wax or material. When using material requiring heat, steam is conveyed into the roll through steam pipe E. The depth to which the roll G is submerged in the substance in the vat or pan, and the shape of the latter conforming to the surface of the roll, enables us to maintain the wax or material at a uniform consistency and temperature throughout the entire mass. The paper or other fabric N as it passes from the machine on which it has been made, or from rolls, reels or spools on which it'may. have been wound, is passed through the machine in the direction shown by the arrows, between carrying rolls D D, under knife Z, between rolls G and H andbetween carrying rolls D D, and from thence disposed of as desired. Whenthe balance weight M is in theposition shown in the drawings, roll H is sus- 6o pended at a sufficient distance above roll G to enable the operator to readily pass the fabric between the rolls untilit is caught between the carrying rolls D' D. Then by means of the connections between roll H and the hand wheel K-to the latter of which is attached the balance weight M whichcan be moved to any point on the rim of the wheel desired and fastened by set screw-roll H is lowered by turning the wheel in the direction shown by the arrow until the balance weight M has reached a point past the center at the top as shown by the dotted lines M. By this operation roll H as it descends bears the fabric down as shown by the dotted line to the surface of roll G where it receives the wax or other substance on the under side of the web. The weight of roll H together with that of the balance weight M exerts a pressure on the fabric between the two rolls, removing any surplus wax or material from the fabric, thus smoothing and calendering its surfaces. The hand wheel K and the eccentrics J J, are keyed to the shaft L. The straps around the eccentrics and the journal boxes I) b in which roll H operates are so constructed as to receive the ends of the'connecting rods I I which are provided with right and left threads. Thus by turning the hand wheel K, roll H is either raised or lowered and by turning the connecting rods I I, the distance between the eccentrics and the journal boxes is either increased or diminished, to adjust the machine to any thickness of fabric between the rolls G and H. Power is applied to the shaft of 5 roll G at the back side of the machine, either by gearing, or by belt and pulleys and transmitted from the shaft of roll G to the shaft of roll H either by belts, pulleys and counter shaft, or preferably by a pair of toothed roe wheels 0 0. Shown by Fig. 7. These wheels are of peculiar pattern, their teeth extending to an edge about one inch beyond their pitch lines, and the surfaces of the rolls respecthang loosely by their upper ends from the opera-ting in slots in the lower endo'f the anively which prevents their ridingmas Wellies causes them to drop into their proper working position, equalizing the speed of the rolls previous to their surfaces coming together on the fabric between them, thus avoiding any strain on the fabric. Should the webof {1 paper, passing into the machine contain broken or unmarketable paper by reason of holes or broken places, such imperfections are detected by the drags or triggersY which pins f on disks-U, while their lower ends rest; lightly on the upper surface of the fabric in front of carrying rolls D D. The-drags or triggers Y, pins f and disks or cams U may be ofany number :required, .and anyone of the drags dropping through such :im-perfections :in ith e' web, the pinor tooth on :the un- 1* derside of'iit eiseaught rbyithe corrugated :roll. t wihichbeing in 'motion drawsthe'tirigger for -1 ward until the tooth :passesont of connection 3 with the roll t. "This .aetiou liiiilIOWS forward the: arm W, bearingtthegadj ustable -=weight X 1 whileale'ver ;T is thrown backwardiand by th-ei: connection elf said ilever through prod *S wi-th the supper endof angle arm R :the knife Z,

gle: arm, and in frames 010 is bronghtdown, severing theweb and preventingsuch .u-nmarketable portion of "the fabric ifrom pass 1 ing toor between the rolls Grand H and being wuselessly treated-with wax or material. The positions of rthe various parts involved: in this last operation areshownbyithe dotted 3 linesin Big. 11. fllhe dragsior triggers Y and their iconn'ections are reset by means of a handle or crank on lever T, the latter as also the cams U, and arm W being keyed to shaft V.

Weareawa e that rim-to our invention vats or "troughs, and eated and other rolls 7 have been used in various forms and ways in machines o waxingiandeeati g pape a other fabrics. We therefore do not claim the use of such broadly; but

What we'dolelaimesonriinxenriony-en esire to secure :by Letters Patent, is-

1. "Ina-machinefor waxing or coating paper or other fabrics the combination of the vat or pan F with the hdllow roll G carrying rolls 5D 1D, and 1D 1D -ad=j ustable or movable press- ;ure wand calender roll H, toothed wheels 0 O,

j ournal boxes b 'b, connecting rods 51 *Leccengtrics J Lsha'ft L, .hand'lwheel K, and'adjustiKIT MCKEAN, A. P. KENT.

US513030D Machine for waxing or coating paper Expired - Lifetime US513030A (en)

Publications (1)

Publication Number Publication Date
US513030A true US513030A (en) 1894-01-16

Family

ID=2581848

Family Applications (1)

Application Number Title Priority Date Filing Date
US513030D Expired - Lifetime US513030A (en) Machine for waxing or coating paper

Country Status (1)

Country Link
US (1) US513030A (en)

Cited By (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2726174A (en) * 1952-07-19 1955-12-06 Roy L Friel Spot carbon printing machine
WO2007115168A2 (en) 2006-03-31 2007-10-11 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of eg5 gene
WO2010068816A1 (en) 2008-12-10 2010-06-17 Alnylam Pharmaceuticals, Inc. Gnaq targeted dsrna compositions and methods for inhibiting expression
WO2010099341A1 (en) 2009-02-26 2010-09-02 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of mig-12 gene
WO2010105209A1 (en) 2009-03-12 2010-09-16 Alnylam Pharmaceuticals, Inc. LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES
WO2011133868A2 (en) 2010-04-22 2011-10-27 Alnylam Pharmaceuticals, Inc. Conformationally restricted dinucleotide monomers and oligonucleotides
WO2011133876A2 (en) 2010-04-22 2011-10-27 Alnylam Pharmaceuticals, Inc. Oligonucleotides comprising acyclic and abasic nucleosides and analogs
EP2392583A1 (en) 2006-05-19 2011-12-07 Alnylam Europe AG. RNAi modulation of Aha and therapeutic uses thereof
WO2012079046A2 (en) 2010-12-10 2012-06-14 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of klf-1 and bcl11a genes
WO2012138453A1 (en) 2011-04-03 2012-10-11 The General Hospital Corporation Efficient protein expression in vivo using modified rna (mod-rna)
WO2012177947A2 (en) 2011-06-21 2012-12-27 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibition of expression of apolipoprotein c-iii (apoc3) genes
WO2012178033A2 (en) 2011-06-23 2012-12-27 Alnylam Pharmaceuticals, Inc. Serpina1 sirnas: compositions of matter and methods of treatment
WO2012177784A2 (en) 2011-06-21 2012-12-27 Alnylam Pharmaceuticals Angiopoietin-like 3 (angptl3) irna compostions and methods of use thereof
WO2013019857A2 (en) 2011-08-01 2013-02-07 Alnylam Pharmaceuticals, Inc. Method for improving the success rate of hematopoietic stem cell transplants
EP2584051A1 (en) 2006-05-22 2013-04-24 Alnylam Pharmaceuticals Inc. Compositions and methods for inhibiting expressions of IKK-B gene
EP2617828A1 (en) 2007-12-10 2013-07-24 Alnylam Pharmaceuticals Inc. Compositions and methods for inhibiting expression of factor VII gene
WO2013155204A2 (en) 2012-04-10 2013-10-17 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of the alas1 gene
EP2690175A2 (en) 2008-09-02 2014-01-29 Alnylam Pharmaceuticals Compositions and methods for combined inhibition of mutant EGFR gene and IL-6 expression
EP2712926A2 (en) 2008-03-05 2014-04-02 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of Eg5 and VEGF genes
WO2014071358A2 (en) 2012-11-05 2014-05-08 Foundation Medicine, Inc. Novel ntrk1 fusion molecules and uses thereof
WO2014130922A1 (en) 2013-02-25 2014-08-28 Trustees Of Boston University Compositions and methods for treating fungal infections
WO2014190137A1 (en) 2013-05-22 2014-11-27 Alnylam Pharmaceuticals, Inc. SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
WO2014190157A1 (en) 2013-05-22 2014-11-27 Alnylam Pharmaceuticals, Inc. Tmprss6 compositions and methods of use thereof
EP2810643A2 (en) 2009-08-14 2014-12-10 Alnylam Pharmaceuticals Inc. Lipid formulated compositions and mehods for inhibiting expression of a gene from the ebola virus
WO2015050990A1 (en) 2013-10-02 2015-04-09 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of the lect2 gene
WO2015107425A2 (en) 2014-01-16 2015-07-23 Wave Life Sciences Pte. Ltd. Chiral design
WO2015123264A1 (en) 2014-02-11 2015-08-20 Alnylam Pharmaceuticals, Inc. Ketohexokinase (khk) irna compositions and methods of use thereof
EP2937418A1 (en) 2008-10-20 2015-10-28 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of transthyretin
WO2015175510A1 (en) 2014-05-12 2015-11-19 Alnylam Pharmaceuticals, Inc. Methods and compositions for treating a serpinc1-associated disorder
WO2015179724A1 (en) 2014-05-22 2015-11-26 Alnylam Pharmaceuticals, Inc. Angiotensinogen (agt) irna compositions and methods of use thereof
WO2016040589A1 (en) 2014-09-12 2016-03-17 Alnylam Pharmaceuticals, Inc. Polynucleotide agents targeting complement component c5 and methods of use thereof
WO2016061487A1 (en) 2014-10-17 2016-04-21 Alnylam Pharmaceuticals, Inc. Polynucleotide agents targeting aminolevulinic acid synthase-1 (alas1) and uses thereof
WO2016069694A2 (en) 2014-10-30 2016-05-06 Alnylam Pharmaceuticals, Inc. Polynucleotide agents targeting serpinc1 (at3) and methods of use thereof
WO2016077321A1 (en) 2014-11-10 2016-05-19 Alnylam Pharmaceuticals, Inc. Hepatitis b virus (hbv) irna compositions and methods of use thereof
WO2016081444A1 (en) 2014-11-17 2016-05-26 Alnylam Pharmaceuticals, Inc. Apolipoprotein c3 (apoc3) irna compositions and methods of use thereof
WO2016130806A2 (en) 2015-02-13 2016-08-18 Alnylam Pharmaceuticals, Inc. Patatin-like phospholipase domain containing 3 (pnpla3) irna compositions and methods of use thereof
WO2016164746A1 (en) 2015-04-08 2016-10-13 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of the lect2 gene
WO2016201301A1 (en) 2015-06-12 2016-12-15 Alnylam Pharmaceuticals, Inc. Complement component c5 irna compositions and methods of use thereof
WO2016205323A1 (en) 2015-06-18 2016-12-22 Alnylam Pharmaceuticals, Inc. Polynucleotde agents targeting hydroxyacid oxidase (glycolate oxidase, hao1) and methods of use thereof
WO2016209862A1 (en) 2015-06-23 2016-12-29 Alnylam Pharmaceuticals, Inc. Glucokinase (gck) irna compositions and methods of use thereof
WO2017011286A1 (en) 2015-07-10 2017-01-19 Alnylam Pharmaceuticals, Inc. Insulin-like growth factor binding protein, acid labile subunit (igfals) and insulin-like growth factor 1 (igf-1) irna compositions and methods of use thereof
WO2017040078A1 (en) 2015-09-02 2017-03-09 Alnylam Pharmaceuticals, Inc. PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
WO2018098117A1 (en) 2016-11-23 2018-05-31 Alnylam Pharmaceuticals, Inc. SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Cited By (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2726174A (en) * 1952-07-19 1955-12-06 Roy L Friel Spot carbon printing machine
WO2007115168A2 (en) 2006-03-31 2007-10-11 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of eg5 gene
EP2392583A1 (en) 2006-05-19 2011-12-07 Alnylam Europe AG. RNAi modulation of Aha and therapeutic uses thereof
EP2584051A1 (en) 2006-05-22 2013-04-24 Alnylam Pharmaceuticals Inc. Compositions and methods for inhibiting expressions of IKK-B gene
EP2848688A1 (en) 2007-12-10 2015-03-18 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of factor VII gene
EP2617828A1 (en) 2007-12-10 2013-07-24 Alnylam Pharmaceuticals Inc. Compositions and methods for inhibiting expression of factor VII gene
EP2712926A2 (en) 2008-03-05 2014-04-02 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of Eg5 and VEGF genes
EP2690175A2 (en) 2008-09-02 2014-01-29 Alnylam Pharmaceuticals Compositions and methods for combined inhibition of mutant EGFR gene and IL-6 expression
EP2937418A1 (en) 2008-10-20 2015-10-28 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of transthyretin
WO2010068816A1 (en) 2008-12-10 2010-06-17 Alnylam Pharmaceuticals, Inc. Gnaq targeted dsrna compositions and methods for inhibiting expression
EP3225281A1 (en) 2008-12-10 2017-10-04 Alnylam Pharmaceuticals, Inc. Gnaq targeted dsrna compositions and methods for inhibiting expression
WO2010099341A1 (en) 2009-02-26 2010-09-02 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of mig-12 gene
WO2010105209A1 (en) 2009-03-12 2010-09-16 Alnylam Pharmaceuticals, Inc. LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES
EP2810643A2 (en) 2009-08-14 2014-12-10 Alnylam Pharmaceuticals Inc. Lipid formulated compositions and mehods for inhibiting expression of a gene from the ebola virus
WO2011133876A2 (en) 2010-04-22 2011-10-27 Alnylam Pharmaceuticals, Inc. Oligonucleotides comprising acyclic and abasic nucleosides and analogs
WO2011133868A2 (en) 2010-04-22 2011-10-27 Alnylam Pharmaceuticals, Inc. Conformationally restricted dinucleotide monomers and oligonucleotides
WO2012079046A2 (en) 2010-12-10 2012-06-14 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of klf-1 and bcl11a genes
WO2012138453A1 (en) 2011-04-03 2012-10-11 The General Hospital Corporation Efficient protein expression in vivo using modified rna (mod-rna)
WO2012177784A2 (en) 2011-06-21 2012-12-27 Alnylam Pharmaceuticals Angiopoietin-like 3 (angptl3) irna compostions and methods of use thereof
WO2012177947A2 (en) 2011-06-21 2012-12-27 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibition of expression of apolipoprotein c-iii (apoc3) genes
EP3366312A1 (en) 2011-06-23 2018-08-29 Alnylam Pharmaceuticals, Inc. Serpina 1 sirnas: compositions of matter and methods of treatment
WO2012178033A2 (en) 2011-06-23 2012-12-27 Alnylam Pharmaceuticals, Inc. Serpina1 sirnas: compositions of matter and methods of treatment
WO2013019857A2 (en) 2011-08-01 2013-02-07 Alnylam Pharmaceuticals, Inc. Method for improving the success rate of hematopoietic stem cell transplants
WO2013155204A2 (en) 2012-04-10 2013-10-17 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of the alas1 gene
WO2014071358A2 (en) 2012-11-05 2014-05-08 Foundation Medicine, Inc. Novel ntrk1 fusion molecules and uses thereof
WO2014130922A1 (en) 2013-02-25 2014-08-28 Trustees Of Boston University Compositions and methods for treating fungal infections
WO2014190157A1 (en) 2013-05-22 2014-11-27 Alnylam Pharmaceuticals, Inc. Tmprss6 compositions and methods of use thereof
WO2014190137A1 (en) 2013-05-22 2014-11-27 Alnylam Pharmaceuticals, Inc. SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
WO2015050990A1 (en) 2013-10-02 2015-04-09 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of the lect2 gene
WO2015107425A2 (en) 2014-01-16 2015-07-23 Wave Life Sciences Pte. Ltd. Chiral design
WO2015123264A1 (en) 2014-02-11 2015-08-20 Alnylam Pharmaceuticals, Inc. Ketohexokinase (khk) irna compositions and methods of use thereof
WO2015175510A1 (en) 2014-05-12 2015-11-19 Alnylam Pharmaceuticals, Inc. Methods and compositions for treating a serpinc1-associated disorder
WO2015179724A1 (en) 2014-05-22 2015-11-26 Alnylam Pharmaceuticals, Inc. Angiotensinogen (agt) irna compositions and methods of use thereof
WO2016040589A1 (en) 2014-09-12 2016-03-17 Alnylam Pharmaceuticals, Inc. Polynucleotide agents targeting complement component c5 and methods of use thereof
WO2016061487A1 (en) 2014-10-17 2016-04-21 Alnylam Pharmaceuticals, Inc. Polynucleotide agents targeting aminolevulinic acid synthase-1 (alas1) and uses thereof
WO2016069694A2 (en) 2014-10-30 2016-05-06 Alnylam Pharmaceuticals, Inc. Polynucleotide agents targeting serpinc1 (at3) and methods of use thereof
WO2016077321A1 (en) 2014-11-10 2016-05-19 Alnylam Pharmaceuticals, Inc. Hepatitis b virus (hbv) irna compositions and methods of use thereof
WO2016081444A1 (en) 2014-11-17 2016-05-26 Alnylam Pharmaceuticals, Inc. Apolipoprotein c3 (apoc3) irna compositions and methods of use thereof
WO2016130806A2 (en) 2015-02-13 2016-08-18 Alnylam Pharmaceuticals, Inc. Patatin-like phospholipase domain containing 3 (pnpla3) irna compositions and methods of use thereof
WO2016164746A1 (en) 2015-04-08 2016-10-13 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of the lect2 gene
WO2016201301A1 (en) 2015-06-12 2016-12-15 Alnylam Pharmaceuticals, Inc. Complement component c5 irna compositions and methods of use thereof
WO2016205323A1 (en) 2015-06-18 2016-12-22 Alnylam Pharmaceuticals, Inc. Polynucleotde agents targeting hydroxyacid oxidase (glycolate oxidase, hao1) and methods of use thereof
WO2016209862A1 (en) 2015-06-23 2016-12-29 Alnylam Pharmaceuticals, Inc. Glucokinase (gck) irna compositions and methods of use thereof
WO2017011286A1 (en) 2015-07-10 2017-01-19 Alnylam Pharmaceuticals, Inc. Insulin-like growth factor binding protein, acid labile subunit (igfals) and insulin-like growth factor 1 (igf-1) irna compositions and methods of use thereof
WO2017040078A1 (en) 2015-09-02 2017-03-09 Alnylam Pharmaceuticals, Inc. PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
WO2018098117A1 (en) 2016-11-23 2018-05-31 Alnylam Pharmaceuticals, Inc. SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Similar Documents

Publication Publication Date Title
US2531036A (en) Apparatus for applying pattern forming material
US312257A (en) hewes
US2107249A (en) Paper-bag-machine attachment
US1642782A (en) Machine for making corrugated paper
US2243604A (en) Device for applying films of coating material to paper webs
US964088A (en) Fabric-stretching machine.
US2614054A (en) Paper reinforcing machine
US1951301A (en) Strand inlaying machine
US444821A (en) Apparatus for making leaf-hinges for books
US1722503A (en) Paper-making method and machine
US2174215A (en) Decatizing fabrics
US993981A (en) Skewer-making machine.
US1867210A (en) Machine for and method of dyeing cloth and otherwise treating textiles
US513030A (en) Machine for waxing or coating paper
US1501179A (en) Felt washer
US2108189A (en) Sizing vat
US1580342A (en) Machine for stacking paper cartons
US2201481A (en) Perforating apparatus
US1926319A (en) Paper making machine
US1627015A (en) Machine for separating and feeding blanks
US1282950A (en) Sheet feeding and gumming machine.
US3029179A (en) Apparatus for producing non-woven or reinforced fabrics
US2007551A (en) Method of and apparatus for making paper board
US1107160A (en) Apparatus for bleaching and scouring fibrous materials.
US1673958A (en) Method and machine for producing printing ribbons